Intermittent vismodegib dosing to treat multiple basal-cell carcinomas

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Academic › peer-review

26 Downloads (Pure)

Keywords

@article{d9a58fdfa1b74ce490404666455b44b5,

title = "Intermittent vismodegib dosing to treat multiple basal-cell carcinomas",

keywords = "DOUBLE-BLIND, TRIAL, NEOADJUVANT, SURGERY",

author = "Klara Mosterd",

year = "2017",

month = mar,

doi = "10.1016/S1470-2045(17)30079-7",

language = "English",

volume = "18",

pages = "284--286",

journal = "Lancet oncology",

issn = "1470-2045",

publisher = "The Lancet Publishing Group",

number = "3",

}

TY - JOUR

T1 - Intermittent vismodegib dosing to treat multiple basal-cell carcinomas

AU - Mosterd, Klara

PY - 2017/3

Y1 - 2017/3

KW - DOUBLE-BLIND

KW - TRIAL

KW - NEOADJUVANT

KW - SURGERY

U2 - 10.1016/S1470-2045(17)30079-7

DO - 10.1016/S1470-2045(17)30079-7

M3 - Editorial

SN - 1470-2045

VL - 18

SP - 284

EP - 286

JO - Lancet oncology

JF - Lancet oncology

IS - 3

ER -